
到 2027 年北美智能吸入器市场 - 按产品(雾化器和吸入器)进行区域分析和预测;疾病(慢性阻塞性肺病(COPD)和哮喘);最终用户(家庭护理机构以及医院和诊所)和国家/地区
No. of Pages: 110 | Report Code: TIPRE00006805 | Category: Life Sciences
No. of Pages: 110 | Report Code: TIPRE00006805 | Category: Life Sciences
北美智能吸入器市场预计将从 2018 年的 5.0391 亿美元增至 2027 年的 37.499 亿美元。预计从 2019 年开始,该市场将以 25.7% 的复合年增长率增长-2027年。
市场的增长是由老年人口增长等因素推动的慢性阻塞性肺病和哮喘的患病率不断上升,人们对健康状况的认识不断提高。然而,由于与网络威胁相关的风险,有关智能吸入器使用的知识有限,市场可能会受到影响。
< p>全球范围内哮喘和慢性阻塞性肺病的病例正在以显着的速度增加。近年来,发达国家和发展中国家的吸烟人数和空气污染都有所增加。哮喘是一种非传染性疾病,表现为反复发作的呼吸困难和喘息,其严重程度和频率因人而异。当哮喘发作时,支气管内壁肿胀,导致气道变窄,从而限制空气进出肺部。复发性哮喘症状经常导致白天疲劳、失眠、活动水平降低以及缺课和缺勤。据世界卫生组织估计,目前全球有 2.35 亿人患有哮喘。根据美国疾病控制与预防中心 (CDC) 的数据,目前美国 18 岁以上成年人患有哮喘的人数约为 1900 万,占成年人口总数的近 7.7%。< /p>
同样,北美地区慢性阻塞性肺病(COPD)的患病率也在上升。慢性阻塞性肺病(COPD)是一种进行性致命性肺部疾病,会导致呼吸困难,导致病情恶化,最后导致严重疾病。根据全球疾病负担研究报告,2016 年全球约有 2.51 亿例慢性阻塞性肺病患病率。据估计,2015 年全球约有 317 万人因慢性阻塞性肺病死亡,占近 5 例。占 2015 年所有死亡人数的百分比。近年来,慢性阻塞性肺病 (COPD) 的患病率在发达国家一直很高。例如,慢性阻塞性肺病被认为是美国第三大疾病死亡原因。大约有 1100 万人被诊断患有慢性阻塞性肺病 (COPD)。因此,哮喘和慢性阻塞性肺病等呼吸系统疾病患病率的上升预计将推动全球智能吸入器市场呈指数级增长。
< /p>
美国预计将引领北美地区的市场,因为美国拥有各种在肺部疾病领域提供帮助的协会。例如,美国肺脏协会开展研究活动、教育和培训,并采取举措为患有哮喘、慢性阻塞性肺病、流感、肺癌、肺炎和肺纤维化等呼吸系统疾病的患者提供更好的治疗和支持。因此,考虑到上述因素,在预测期内,该国市场的增长可能会在北美地区贡献最大份额。
图表:2027 年墨西哥智能吸入器市场收入和预测(百万美元)
< /span>
北美智能吸入器 -市场细分
按产品强>
按无序
最终用户
按地理位置
公司简介
Strategic insights for North America Smart Inhalers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2018 | US$ 503.91 Million |
Market Size by 2027 | US$ 3,749.90 Million |
Global CAGR (2019 - 2027) | 25.7% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Smart Inhalers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The North America Smart Inhalers Market is valued at US$ 503.91 Million in 2018, it is projected to reach US$ 3,749.90 Million by 2027.
As per our report North America Smart Inhalers Market, the market size is valued at US$ 503.91 Million in 2018, projecting it to reach US$ 3,749.90 Million by 2027. This translates to a CAGR of approximately 25.7% during the forecast period.
The North America Smart Inhalers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Smart Inhalers Market report:
The North America Smart Inhalers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Smart Inhalers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Smart Inhalers Market value chain can benefit from the information contained in a comprehensive market report.